The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Hyun Kuk Kim(Chosun University Hospital), Young‐Hoon Jeong(Changwon National University), Paul A. Gurbel(Sinai Hospital), Satoshi Yasuda(National Cerebral and Cardiovascular Center), Wen‐Jone Chen(National Taiwan University), Duk‐Woo Park(Ulsan College), Do‐Sun Lim(Korea University Medical Center), Shinya Goto(Tokai University), Gregory Y.H. Lip(University of Liverpool), Dominick J. Angiolillo(Jacksonville University), Diana A. Gorog(University of Hertfordshire), Sidney C. Smith(Brigham and Women's Hospital), Mark Y. Chan(National University Heart Centre Singapore), Bo Zheng(Peking University), Dirk Sibbing(LMU Klinikum), Yong Huo, Eun‐Seok Shin(Ulsan University Hospital), Moo Hyun Kim(Dong-A University Hospital), Tobias Geisler(University Children's Hospital Tübingen), Takeshi Kimura(Kyoto University), Seung‐Jung Park(Samsung Medical Center), Shao-Liang Chen(Nanjing Medical University), Udaya S. Tantry(Sinai Hospital), Myung Ho Jeong(Chonnam National University Hospital), Dániel Aradi(Semmelweis University)
Cited by 334
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k